Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis
European Journal of Dermatology · 2023-10 · 33 (5) · 558-559
DOI: 10.1684/ejd.2023.4566 ↗Kurz gefasst
Fallbericht in der Zeitschrift European Journal of Dermatology, 2023-10. Verfasst von Hirofumi Kamada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Iwate Medical University School of Medicine. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Drug Eruptions. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Iwate Medical University School of Medicine.
- Department of Molecular Diagnostic Pathology, Iwate Medical University School of Medicine.
Zitieren
APA
Kamada, H., Arakawa, N., Fukui, R., Tanji, T., Watabe, D., Sugai, T., & Amano, H. (2023). Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis. European Journal of Dermatology, 33(5), 558-559. https://doi.org/10.1684/ejd.2023.4566
Vancouver
Kamada H, Arakawa N, Fukui R, Tanji T, Watabe D, Sugai T, et al. Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis. European Journal of Dermatology. 2023;33(5):558-559. doi:10.1684/ejd.2023.4566
BibTeX
@article{Kamada2023,
author = {Kamada, Hirofumi and Arakawa, Nobuyuki and Fukui, Reimu and Tanji, Takayuki and Watabe, Daisuke and Sugai, Tamotsu and Amano, Hiroo},
title = {Nemolizumab-induced drug eruption in a 46-year-old male patient with atopic dermatitis},
journal = {European Journal of Dermatology},
year = {2023},
volume = {33},
number = {5},
pages = {558--559},
doi = {10.1684/ejd.2023.4566}
}
EUVIMED